2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC2668 | |||||||||||||||||||||||
Submitter : | Ms. Cass Nelson-Dooley | Date & Time: | 02/16/2006 12:02:52 | |||||||||||||||||||||
Organization : | Ms. Cass Nelson-Dooley | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
It should be legal to produce bio-identical hormones by compounding pharmacies and by private pharmaceutical companies. There is not sufficient evidence that these supplements have caused harm. Rather, they have caused competition uncomfortable to the pharmaceutical company. | ||||||||||||||||||||||||